RARS2

arginyl-tRNA synthetase 2, mitochondrial, the group of Aminoacyl tRNA synthetases, Class I

Basic information

Region (hg38): 6:87513459-87590028

Previous symbols: [ "RARSL" ]

Links

ENSG00000146282NCBI:57038OMIM:611524HGNC:21406Uniprot:Q5T160AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • pontocerebellar hypoplasia type 6 (Definitive), mode of inheritance: AR
  • pontocerebellar hypoplasia type 6 (Strong), mode of inheritance: AR
  • pontocerebellar hypoplasia type 6 (Strong), mode of inheritance: AR
  • pontocerebellar hypoplasia type 6 (Strong), mode of inheritance: AR
  • pontocerebellar hypoplasia type 6 (Supportive), mode of inheritance: AR
  • complex neurodevelopmental disorder (Limited), mode of inheritance: AD
  • pontocerebellar hypoplasia type 6 (Strong), mode of inheritance: AR
  • mitochondrial disease (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Pontocerebellar hypoplasia, type 6ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic17847012; 20635367; 22569581; 25809939

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the RARS2 gene.

  • not provided (51 variants)
  • Pontocerebellar hypoplasia type 6 (13 variants)
  • Inborn genetic diseases (2 variants)
  • Pontoneocerebellar hypoplasia (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RARS2 gene is commonly pathogenic or not. These statistics are base on trasncript: . Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
180
clinvar
1
clinvar
183
missense
1
clinvar
16
clinvar
120
clinvar
8
clinvar
3
clinvar
148
nonsense
21
clinvar
28
clinvar
49
start loss
4
5
9
frameshift
25
clinvar
52
clinvar
2
clinvar
79
splice donor/acceptor (+/-2bp)
8
clinvar
52
clinvar
60
Total 59 153 124 188 4

Highest pathogenic variant AF is 0.0000262795

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RARS2protein_codingprotein_codingENST00000369536 2075626
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
7.74e-140.84412564501031257480.000410
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.06503083051.010.00001593780
Missense in Polyphen101118.720.850781392
Synonymous-0.7351151051.090.000005621068
Loss of Function1.952740.30.6690.00000204472

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0009410.000941
Ashkenazi Jewish0.00009930.0000992
East Asian0.0006530.000653
Finnish0.00004620.0000462
European (Non-Finnish)0.0005020.000501
Middle Eastern0.0006530.000653
South Asian0.0003590.000359
Other0.0003270.000326

dbNSFP

Source: dbNSFP

Disease
DISEASE: Pontocerebellar hypoplasia 6 (PCH6) [MIM:611523]: A disorder characterized by an abnormally small cerebellum and brainstem, infantile encephalopathy, generalized hypotonia, lethargy and poor feeding. Recurrent apnea, intractable seizures occur early in the course of this condition. {ECO:0000269|PubMed:17847012}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Aminoacyl-tRNA biosynthesis - Homo sapiens (human);Hyperornithinemia with gyrate atrophy (HOGA);Creatine deficiency, guanidinoacetate methyltransferase deficiency;L-arginine:glycine amidinotransferase deficiency;Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome];Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency);Prolinemia Type II;Prolidase Deficiency (PD);Arginine and Proline Metabolism;Hyperprolinemia Type I;Hyperprolinemia Type II;Ornithine Aminotransferase Deficiency (OAT Deficiency);Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency);tRNA Aminoacylation;Translation;Metabolism of proteins;tRNA charging;Urea cycle and metabolism of arginine, proline, glutamate, aspartate and asparagine;Mitochondrial tRNA aminoacylation (Consensus)

Recessive Scores

pRec
0.123

Intolerance Scores

loftool
0.879
rvis_EVS
-0.13
rvis_percentile_EVS
43.91

Haploinsufficiency Scores

pHI
0.504
hipred
N
hipred_score
0.476
ghis
0.615

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.964

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Rars2
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype;

Zebrafish Information Network

Gene name
rars2
Affected structure
midbrain hindbrain boundary
Phenotype tag
abnormal
Phenotype quality
dorso-ventrally flattened

Gene ontology

Biological process
tRNA aminoacylation for protein translation;arginyl-tRNA aminoacylation;mitochondrial translation
Cellular component
mitochondrion;mitochondrial matrix
Molecular function
RNA binding;arginine-tRNA ligase activity;ATP binding